10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
The HA receptor CD44/RHAMM mediates cell-cell/matrix interactions and up-regulation of HA (around 12-fold increase) is observed in PC [130,131,132,133]
Vincent and Intermountain Health, our 12 primary care clinics, and specialty clinics in and around the Billings area, our goal is to help you live the healthiest lives possible
Concurrent medications : Your provider reviews other glucose-lowering medications, particularly insulin or sulfonylureas, which may require dose reduction when initiating GLP-1 therapy to prevent hypoglycemia
Efficacy of anti-sebum moisturizing cream containing 2% L-carnitine and 5% epigallocatechin gallate in seborrhea: a randomized clinical trial
L-carnitine is also used to treat a rare genetic disorder in dogs, L-carnitine deficiency